Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.050

€0.050

-2.940%
-0.0015
-2.940%
-
 
18.09.24 / Stuttgart Stock Exchange WKN: 932414 / Name: MedMira / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medmira Inc. Stock

A loss of -2.940% shows a downward development for Medmira Inc..

Pros and Cons of Medmira Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medmira Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medmira Inc. -2.940% 3.125% -9.174% -10.811% -23.846% - -
Theralase Technologies Inc -3.400% -0.500% -9.545% -34.967% -4.327% -22.266% -30.662%
Atossa Genetics Inc 0.460% -6.686% 10.499% 73.163% 36.451% -57.763% -30.557%
NetScientific plc -0.850% 0.000% -4.918% -9.375% -4.918% -54.688% -4.918%

News

Clinical Trials to get Underway with Multiplo® Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada: https://www.irw-press.at/prcom/images/messages/2024/76536/MedMira_14082024_ENPRcom.001.png
Clinical Trials to get Underway with Multiplo® Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada

Halifax, Nova Scotia, 13 August, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces it will conduct full clinical trials for its unique Multiplo® Complete Syphilis (TP/nTP) Antibody

MedMira Announces the Hire of Vice President of Business Development
MedMira Announces the Hire of Vice President of Business Development

Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the

MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt
MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt

Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the